Three-year experience of using venovenous extracorporeal membrane oxygenation for patients with severe respiratory failure

Hong Kong Medical Journal

Volumn 20, Issue 5, 2014, Pages 407-412

  Ng, George W Y ^a   Leung, Anne K H ^a   Sin, K C ^a   Au, S Y ^a   Chan, Stanley C H ^a   Chan, Osburga P K ^a   Wu, Helen H L ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; HEPARIN; NARCOTIC AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AIR EMBOLISM; ARTICLE; BLEEDING; BLOOD VESSEL INJURY; BRAIN HEMORRHAGE; CANNULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; HEMOFILTRATION; HUMAN; HYPOXEMIA; INFLUENZA VIRUS A H1N1; MALE; MECHANICAL VENTILATOR; MORTALITY; OBSERVATIONAL STUDY; OXYGENATOR; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOSIS; VIRUS INFECTION; HONG KONG; INFLUENZA, HUMAN; INTENSIVE CARE UNIT; PNEUMONIA, VIRAL; PROCEDURES; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

ADULT; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HONG KONG; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; MALE; PNEUMONIA, VIRAL; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 84929935256     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: 10.12809/hkmj144211     Document Type: Article

References (21)

1. Bernard GR, Artigas A, Brigham KL, et al. The American- European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
2. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012;307:2526-33.
3. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374:1351-63.
4. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2:319-23.
5. Hill JD, De Leval MR, Fallat RJ, et al. Acute respiratory insufficiency. Treatment with prolonged extracorporeal oxygenation. J Thorac Cardiovasc Surg 1972;64:551-62.
6. Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;149:295-305.
7. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979;242:2193-6.
8. Extracorporeal Life Support Organization. ECLS Registry Report. International Summary. Jul 2013.
9. Villar J, Slutsky AS. Is the outcome from acute respiratory distress syndrome improving? Curr Opin Crit Care 1996;2:79-87.
10. Phua J, Badia JR, Adhikari NK, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009;179:220-7.
11. Tremblay LN, Slutsky AS. Ventilator-induced lung injury: from the bench to the bedside. Intensive Care Med 2006;32:24-33.
12. Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 1994;22:1568-78.
13. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8.
14. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009;302:1888-95.
15. Extracorporeal Life Support Organization. H1N1 ECMO Registry (as of April 13, 2011). ECLS Registry Report.
16. Chan KK, Lee KL, Lam PK, Law KI, Joynt GM, Yan WW. Hong Kong’s experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1). Hong Kong Med J 2010;16:447-54.
17. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302:1872-9.
18. Nimmerjahn F, Dudziak D, Dirmeier U, et al. Active NFkappaB signalling is a prerequisite for influenza virus infection. J Gen Virol 2004;85:2347-56.
19. Geiler J, Michaelis M, Naczk P, et al. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of proinflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem Pharmacol 2010;79:413-20.
20. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989;37:501-6.
21. Garozzo A, Tempera G, Ungheri D, Timpanaro R, Castro A. N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection. Int J Immunopathol Pharmacol 2007;20:349-54.